India · Delayed Price · Currency is INR Emcure Pharmaceuticals Company Description
Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide.
It offers products in various therapeutic areas, such gynaecology, cardiovascular, blood-related, pain and analgesics, oncology/anti-neoplastics, anti-infectives, vitamins, minerals and nutrients, respiratory, HIV antivirals, Metabolics, gastro, anti-diabetic, neuro, derma, and mRNA vaccine.
It provides its products under Orofer-Xt, Zostum, Bevon, Amaryl M, Orofer Fcm, Maxtra, Clexane, Metpure-Xl, Amaryl, Spegra, Feronia-Xt, Cardace, Pause, Lornit, Targocid, Orofer-S, Lasilactone, Gros, Orofer-Xt Liq, And Tenectase brand names.
Emcure Pharmaceuticals Limited has a strategic partnership with Novo Nordisk India Pvt Ltd. for the development and commercialization of Poviztra, a semaglutide injection for weight loss.
Emcure Pharmaceuticals Limited was incorporated in 1981 and is based in Pune, India.
| Country | India |
| Founded | 1981 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 6,914 |
| CEO | Satish Mehta |
Contact Details
Address: Plot No. P-1 and P-2 Pune, Maharashtra 411057 India | |
| Phone | 91 20 3507 0033 |
| Website | emcure.com |
Stock Details
| Ticker Symbol | 544210 |
| Exchange | Bombay Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Satish Mehta | Chief Executive Officer |
| Tajuddin Shaikh | Chief Financial Officer |
| Samit Mehta | Chief Operating Officer |